Review of iNova Phramaceuticals' bid for Juno PC back on track in Australia following two-month pause
A decision on whether iNova Pharmaceuticals’ plan to buy Australian pharmaceutical joint venture Juno PC should go ahead could come on Dec. 19, after Australia’s competition regulator stopped the clock on...To view the full article, register now.
Already a subscriber? Click here to view full article